XT
VNDA icon

XTX Topco’s Vanda Pharmaceuticals VNDA Stock Holding History

XTX Topco’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
+33,271
New +$217K ﹤0.01% 3238
2025
Q4 		– Sell
-30,121
Closed -$150K – 3853
2025
Q3 		$150K Sell
30,121
-1,403
-4% -$6.5K 0.01% 1933
2025
Q2 		$149K Sell
31,524
-37,805
-55% -$165K 0.01% 1792
2025
Q1 		$318K Buy
69,329
+54,833
+378% +$256K 0.02% 1359
2024
Q4 		$69.4K Buy
+14,496
New +$69.6K 0.01% 1839
2024
Q3 		– Sell
-13,278
Closed -$75K – 2654
2024
Q2 		$75K Buy
+13,278
New +$68.6K 0.01% 1455
2024
Q1 		– Sell
-36,924
Closed -$156K – 2363
2023
Q4 		$156K Sell
36,924
-25,590
-41% -$103K 0.03% 1038
2023
Q3 		$270K Buy
62,514
+37,109
+146% +$206K 0.05% 801
2023
Q2 		$167K Sell
25,405
-573
-2% -$3.67K 0.03% 1069
2023
Q1 		$176K Sell
25,978
-20,724
-44% -$146K 0.04% 991
2022
Q4 		$345K Buy
+46,702
New +$455K 0.07% 503

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's VNDA Position: Q2 2026 in Review

XTX Topco opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 33,271 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #3238 among its holdings. This is a return to the name: XTX Topco previously reported a position in VNDA as recently as Q3 2025.

XTX Topco first reported a position in VNDA in Q4 2022 and has held it in 11 quarters since. The position peaked at $345K in Q4 2022. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • XTX Topco held 33,271 shares of Vanda Pharmaceuticals worth $204K as of Q2 2026.
  • Vanda Pharmaceuticals was a new XTX Topco position in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3238 holding.
  • XTX Topco first reported a position in Vanda Pharmaceuticals in Q4 2022 and has held it in 11 quarters since.
  • XTX Topco's Vanda Pharmaceuticals position peaked at $345K in Q4 2022.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.